早期胃癌患者内镜黏膜下剥离术后复发的相关危险因素

Abstract
Figure/Table
References (20)
Related Citation (15)

Download: PDF (0 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the risk factors of recurrence in patients with early gastric cancer after endoscopic submucosal dissection (ESD).Methods The clinical data of 176 patients with early gastric cancer admitted to Xiaogan Hospital Affiliated to Wuhan University of Science and Technology from June 2019 to June 2021 were retrospectively analyzed.All patients successfully completed ESD.They were followed up for 1 year,and were divided into recurrence group (n=25) and non-recurrence group (n=151) according to the presence or absence of recurrence.General information of two groups including gender,age,tumor location,diabetes mellitus,tumor diameter,degree of differentiation,depth of tumor invasion,smoking history,whether endoscopy was performed before surgery,the nature of surgical margins,the number of positive lymph nodes were statistically analyzed,and the related risk factors for recurrence after ESD were analyzed.Results After ESD treatment,25 of 176 patients with gastric cancer recurred,and the recurrence rate was 14.20%.The univariate analysis showed that the tumor diameter≥3 cm,the depth of tumor invasion was submucosal,no preoperative endoscopy,positive surgical margins,and the number of positive lymph nodes ≥6 were related to the recurrence of early gastric cancer after ESD,and the differences were statistically significant (P＜0.05).Gender,age,tumor location,combined diabetes,degree of differentiation,smoking history were not related to the recurrence of early gastric cancer after ESD,and the differences were not statistically significant (P＞0.05).Multivariate analysis of the logistic regression model showed that the tumor diameter≥3 cm (β=2.512, OR=12.324,95%CI=4.322-35.141),the depth of tumor invasion was submucosal (β=1.947, OR=7.007,95%CI=2.629-18.677),no preoperative endoscopy (β=2.215, OR=9.164,95%CI=2.992-28.070),positive surgical margins (β=2.080, OR=8.005,95%CI=3.170-20.212),the number of positive lymph nodes≥6 (β=1.898, OR=6.673,95%CI=2.600-17.132) were independent risk factors for early gastric cancer recurrence after ESD (P＜0.05 and OR≥1).Conclusion Patients with early gastric cancer have a higher risk of recurrence after ESD,which is mainly affected by factors such as tumor diameter ≥3 cm,the depth of tumor invasion was submucosal,no preoperative endoscopy,positive surgical margins,and number of positive lymph nodes ≥6.Great attention should be paid in clinical practice.

Key words： Early gastric cancer Endoscopic submucosal dissection Recurrence Risk factors

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHONG Bibo
	ZHONG Fang

Cite this article:

ZHONG Bibo,ZHONG Fang. Risk factors for recurrence after endoscopic submucosal dissection in patients with early gastric cancer[J]. 中国当代医药, 2022, 29(17): 104-107.

URL:

https://www.dangdaiyiyao.com/EN/ OR https://www.dangdaiyiyao.com/EN/Y2022/V29/I17/104

[1]	杨暄，李定国，孔莉.内镜黏膜下剥离术治疗早期胃癌及癌前病变的疗效观察[J].海南医学，2019，30（9）：1127-1129.
[2]	李生利，陈克河，李士坤，等.内镜黏膜下剥离术治疗早期胃癌的效果研究[J].癌症进展，2021，19（7）：703-705，709.
[3]	王珣，曾会，陈志娟，等.内镜黏膜下剥离术治疗早期胃癌或胃癌前病变临床效果及并发出血影响因素分析[J].临床误诊误治，2021，34（1）：82-86.
[4]	沙林玉，倪永，李培培，等.内镜黏膜下剥离术治疗未分化型早期胃癌的疗效分析[J].中华消化内镜杂志，2020，37（5）：326-330.
[5]	刘苗，王英南，张韶辰，等.影响胃癌根治术后早期复发的危险因素分析[J].临床肿瘤学杂志，2020，25（10）：905-910.
[6]	中华人民共和国国家卫生和计划生育委员会.胃癌规范化诊疗指南（试行）[J].中国医学前沿杂志（电子版），2013，5（8）：56-63.
[7]	高境蔚.内镜下两种手术方式治疗早期胃癌的疗效及对患者围术期指标、复发率和并发症的影响[J].实用癌症杂志，2020，35（9）：1489-1492.
[8]	褚宇宁，毛涛，荆雪，等.未分化型早期胃癌内镜黏膜下剥离术扩大适应证的可行性探讨[J].中华消化杂志，2020，40（1）：30-35.
[9]	宋超，张永欢，黄莉.内镜黏膜下剥离术和内镜黏膜切除术治疗早期胃癌和癌前病变的疗效以及对血清胃蛋白酶原的影响[J].广西医学，2020，42（22）：2943-2947.
[10]	杨敏，李会玲，赵民艳.早期胃癌患者采用ESD 和传统手术治疗的临床效果对比分析[J].中国老年学杂志，2019，39（9）：2105-2107.
[11]	李军，施毅卿，姜松耀.内镜辅助胃癌黏膜下剥离术治疗胃癌前病变及早期胃癌效果分析[J].临床和实验医学杂志，2018，17（6）：637-640.
[12]	许真真，陈湘玉，李雯，等.上消化道早癌内镜黏膜下剥离术后患者癌症复发恐惧现状及影响因素分析[J].现代消化及介入诊疗，2020，25（10）：1290-1295.
[13]	邓曦祥.早期胃癌和癌前病变内镜下黏膜剥离术治疗后复发的预测因子分析[J].现代消化及介入诊疗，2019，24（10）：1166-1168.
[14]	高先海，付晨雪，白洋泽.消化内镜下黏膜剥离术治疗早期胃癌的效果及对炎症因子、复发的影响[J].中国当代医药，2021，28（32）：99-101，112.
[15]	王薇，任彦，付肖岩，等.内镜黏膜下剥离术和内镜黏膜切除术治疗直肠神经内分泌肿瘤的临床评价[J].中国医药科学，2020，10（17）：245-249.
[16]	张庆瑞，郭春光，张月明，等.内镜黏膜下剥离术与外科手术治疗未分化型早期胃癌远期疗效对比[J].中华胃肠外科杂志，2021，24（5）：413-419.
[17]	吴杨庆，桑建忠，周建波，等.胃低级别上皮内瘤变内镜黏膜下剥离术后病理升级的危险因素分析[J].中国内镜杂志，2020，26（5）：1-6.
[18]	金灿，邹传鑫，杨继元.内镜黏膜下剥离术治疗老年早期胃癌预后的危险因素[J].中国临床研究，2020，33（3）：374-376.
[19]	张波，令狐恩强，柴宁莉，等.内镜黏膜下剥离术治疗胃黏膜病变术后复发相关因素分析[J].中华消化内镜杂志，2018，35（1）：32-36.
[20]	李韶华，谢华红，幺立萍，等.内镜黏膜下剥离术治疗早期胃癌复发及影响因素分析[J].临床误诊误治，2019，32（9）：58-61.